Krazati(Adagrasib) Side Effects

Common side effects include nausea, diarrhea, and fatigue. Serious side effects include QTc prolongation and liver toxicity.

Adverse Reactions

Common effects for NSCLC: Nausea, diarrhea, fatigue, muscle, and bone pain.

Common effects for CRC with cetuximab: Skin rash, diarrhea, nausea, and low red blood cell count.

Serious side effects: Liver problems (jaundice, dark urine), lung inflammation, and QTc prolongation. Some side effects may require stopping or modifying the treatment.

Adagrasib(Krazati)
Locally advanced or metastatic NSCLC harboring KRAS G12C mutation who have received at least one systemic therapy.
RELATED ARTICLES
Efficacy of Adagrasib

Adagrasib was developed by Mirati Therapeutics. Its unique pharmacological effects and good efficacy have made...

Wednesday, July 2nd, 2025, 15:48
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved